Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.08

Margin Of Safety %

Put/Call OI Ratio

0.3

EPS Next Q Diff

-0.66

EPS Last/This Y

1.99

EPS This/Next Y

1.95

Price

15.65

Target Price

10.5

Analyst Recom

4.33

Performance Q

68.09

Relative Volume

0.94

Beta

0.79

Ticker: AMRN




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02AMRN11.780.090.2416072
2025-06-03AMRN120.090.2616096
2025-06-04AMRN11.810.090.1716139
2025-06-05AMRN11.790.090.0216179
2025-06-06AMRN12.760.090.0516235
2025-06-09AMRN12.350.090.5716159
2025-06-10AMRN12.790.100.0216564
2025-06-11AMRN13.30.100.2316244
2025-06-12AMRN13.330.100.2516297
2025-06-13AMRN13.250.110.3116620
2025-06-16AMRN13.890.110.5816656
2025-06-17AMRN13.350.110.0516662
2025-06-18AMRN13.310.110.7716811
2025-06-20AMRN12.520.110.1216784
2025-06-23AMRN12.70.180.487038
2025-06-24AMRN16.030.190.397150
2025-06-25AMRN16.170.261.028773
2025-06-26AMRN15.90.302.639526
2025-06-27AMRN15.690.302.039595
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02AMRN11.76-405.0- -2.01
2025-06-03AMRN11.95-405.0- -2.01
2025-06-04AMRN11.79-405.0- -2.01
2025-06-05AMRN11.85-405.0- -2.01
2025-06-06AMRN12.73-405.0- -2.01
2025-06-09AMRN12.33-405.0- -2.01
2025-06-10AMRN12.78-405.0- -2.01
2025-06-11AMRN13.33-405.0- -2.01
2025-06-12AMRN13.38-405.0- -2.01
2025-06-13AMRN13.15-405.0- -2.01
2025-06-16AMRN13.85-405.0- -2.01
2025-06-17AMRN13.34-405.0- -2.01
2025-06-18AMRN13.33-405.0- -2.01
2025-06-20AMRN12.54-405.0- -2.01
2025-06-23AMRN12.61-405.0- -2.01
2025-06-24AMRN16.06-405.0- -2.01
2025-06-25AMRN16.18-405.0- -2.01
2025-06-26AMRN15.83-405.0- -2.01
2025-06-27AMRN15.65-405.0- -2.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02AMRN0.001.522.71
2025-06-03AMRN0.001.522.71
2025-06-04AMRN0.001.522.71
2025-06-05AMRN0.001.522.71
2025-06-06AMRN0.001.522.71
2025-06-09AMRN0.001.512.71
2025-06-11AMRN0.001.512.42
2025-06-12AMRN0.001.512.42
2025-06-13AMRN0.001.512.42
2025-06-16AMRN0.001.472.42
2025-06-17AMRN0.001.472.42
2025-06-18AMRN0.001.472.42
2025-06-19AMRN0.001.472.42
2025-06-20AMRN0.001.472.42
2025-06-24AMRN0.001.372.42
2025-06-25AMRN0.001.372.42
2025-06-26AMRN0.001.372.08
2025-06-27AMRN0.001.372.08
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.04

Avg. EPS Est. Current Quarter

-0.61

Avg. EPS Est. Next Quarter

-0.7

Insider Transactions

Institutional Transactions

1.37

Beta

0.79

Average Sales Estimate Current Quarter

53

Average Sales Estimate Next Quarter

41

Fair Value

Quality Score

36

Growth Score

28

Sentiment Score

98

Actual DrawDown %

91.5

Max Drawdown 5-Year %

-95.5

Target Price

10.5

P/E

Forward P/E

PEG

P/S

1.52

P/B

0.69

P/Free Cash Flow

EPS

-4.27

Average EPS Est. Cur. Y​

-2.01

EPS Next Y. (Est.)

-0.06

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

-40.99

Relative Volume

0.94

Return on Equity vs Sector %

-42.5

Return on Equity vs Industry %

-50.7

EPS 1 7Days Diff

1.2

EPS 1 30Days Diff

1.19

EBIT Estimation

Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading